Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma.
Leah Ishmael, Thomas Casale, Juan Carlos Cardet
https://pubmed.ncbi.nlm.nih.gov/39194521/Actively Recruiting
Led by Juan Carlos Cardet · Updated on 2026-09-14
40
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating a new approach to help adults with asthma receive follow-up care after an emergency room ER visit for an asthma attack. This study compares a direct telehealth appointment with an asthma specialist scheduled before leaving the ER to the usual care, which includes a standard referral but no scheduled appointment. The goal is to see if this method increases follow-up visits and improves asthma management, potentially reducing future ER visits. Participants in the intervention group will have an asthma specialist appointment arranged via telehealth within 1 to 3 weeks after the ER visit. Both groups will be offered a prescription for standard twice-daily inhaled corticosteroidlong-acting beta-agonist therapy at discharge. The study includes asthma-related surveys and questionnaires during the ER visit and at a 3-month follow-up call. During the study, participants will complete asthma control assessments and answer questions about medication side effects and follow-up care. Researchers will measure the proportion of patients completing specialist visits within three months, asthma control test scores, quality of life, medication adherence, and rates of repeat ER visits and hospitalizations. The study lasts at least three months, with monitoring focused on outcomes after the ER discharge.
CONDITIONS
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
A
Amanda McNamara, BA, LPN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Juan Carlos Cardet
Lead Sponsor
Tampa General Hospital
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | ER-Initiated Telehealth Referral | Usual Care |
|---|---|---|
| What is it? | A program in which emergency department staff proactively schedule a telehealth visit with an asthma specialist before the patient is discharged, aiming to ensure timely specialist follow-up. Participants also receive a prescription for controller therapy. | Standard procedure in which patients are discharged from the emergency department with a prescription for controller therapy but no scheduled specialist follow-up. The patient is responsible for arranging any further specialty care on their own. |
| Role in the trial | Represents the investigational intervention designed to test whether directly scheduling a telehealth specialist visit from the ER can increase timely asthma specialty follow-up. | Serves as the control group reflecting current real-world practice, where no active scheduling of specialty follow-up occurs at discharge. |
| Primary use or intent | To determine if proactive ER-initiated telehealth referral increases the rate of completed follow-up visits with an asthma specialist after an asthma-related emergency visit. | Acts as a comparison to the intervention; reflects usual follow-up rates when no coordinated referral system is in place after an emergency department visit. |
| How it is delivered or performed | ED staff contact the specialist clinic and arrange a telehealth visit for the patient before hospital discharge. The visit typically occurs within 1-3 weeks post-discharge and addresses symptom review, medication use, and follow-up needs. All participants are prescribed controller therapy. | Patient is discharged with a controller prescription but must arrange any specialty follow-up on their own if desired. There is no proactive scheduling or systemic support from the ER staff for specialist appointments. |
| Evidence maturity / clinical context | ER-initiated telehealth referral is under investigation in this trial. Evidence from observational studies outside the trial indicates telehealth for asthma follow-up is acceptable and may improve specialist access, especially for underrepresented groups. However, randomized clinical trial evidence for direct ER-initiated scheduling impacting long-term asthma outcomes is limited. | Usual care is established as the common real-world pathway following an asthma-related emergency visit, but follow-up rates with asthma specialists remain low and care gaps are commonly observed. |
| Important limitations | As this process is investigational, its effect on asthma control, adverse event reduction, and health equity is not yet established. Implementation depends on availability of specialists, telehealth infrastructure, and patient comfort with remote care. | Usual care is associated with significant care gaps: many patients do not receive timely specialist follow-up after emergency asthma treatment, and persistent disparities in access to specialty care persist for many populations. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit in the emergency room
Duration - 3 months
Participants receive either a telehealth appointment scheduled directly from the emergency room or usual care referral. All participants are offered standard twice-daily asthma controller medication at discharge. Asthma surveys and questionnaires are completed during the ER visit and at a 3-month follow-up call.
1 telehealth or in-person visit plus 1 follow-up phone call
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Leah Ishmael, Thomas Casale, Juan Carlos Cardet
https://pubmed.ncbi.nlm.nih.gov/39194521/Israel C Ugalde, Amanda Ratigan, Conner Merriman...
https://pubmed.ncbi.nlm.nih.gov/37490981/Jonathan W Inselman, Molly M Jeffery, Jacob T Maddux...
https://pubmed.ncbi.nlm.nih.gov/31472294/Mohsen Yaghoubi, Amin Adibi, Abdollah Safari...
https://pubmed.ncbi.nlm.nih.gov/31166782/Bonnie B Dean, Brian C Calimlim, Patricia Sacco...
https://pubmed.ncbi.nlm.nih.gov/20825674/Tursynbek Nurmagambetov, Robin Kuwahara, Paul Garbe
https://pubmed.ncbi.nlm.nih.gov/29323930/National Asthma Education and Prevention Program
https://pubmed.ncbi.nlm.nih.gov/17983880/Tara Carr, Joseph Tkacz, Yen Chung...
https://pubmed.ncbi.nlm.nih.gov/38508336/Roland Buhl, Elisabeth Bel, Arnaud Bourdin...
https://pubmed.ncbi.nlm.nih.gov/34763123/Rini Patadia, Thomas B Casale, John Fowler...
https://pubmed.ncbi.nlm.nih.gov/38619468/Juan Carlos Cardet
Lead Sponsor
Tampa General Hospital
Collaborating Sponsor